Late-breaking poster to feature new positive cardiopulmonary function results from the DELIVER trial of z-rostudirsen in DMD -- Oral ...
Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor ...
Second-highest abstract submissions on record, 96 live oral presentations, more than 400 posters, and global leaders ...
Clinical data disclosed in November 2025 to be presented at medical meeting with new supportive translational data for both programs Vispa-cel (CB-010) ANTLER phase 1 translational and clinical data ...
CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative ...
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present two posters featuring real-world data from its portfolio of differentiated pain medications at PainConnect 2026, the ...
The MarketWatch News Department was not involved in the creation of this content. Sustained execution and high-impact data across HanchorBio's next-generation immuno-oncology portfolio to be featured ...
The CitiesAlive 2026 in Brooklyn this September Call for Proposals & Research Papers is Open & the Deadline to Submit is ...
Blueprint Medicines, a Sanofi company, today announced AYVAKIT(R) (avapritinib) data showing clinically meaningful outcomes and a w ...
This year, to help celebrate the 60th birthday of field-flow fractionation (FFF), scientists are gathering at the Herbert ...
May 2026 at the Cape Town International Convention Centre, featuring Study Group Day, new program innovations, ...
The meeting will feature sessions on AI in heart failure, advanced LVAD technologies, cardiac xenotransplantation, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results